Market Cap : 4.11 B | Enterprise Value : 4.7 B | PE Ratio : At Loss | PB Ratio : 7.92 |
---|
NAS:GH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:GH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Guardant Health's Total Assets for the quarter that ended in Mar. 2022 was $2,129.6 Mil.
Warning Sign:
If a company builds asset at 107.2% a year, faster than its revenue growth rate of 56.7% over the past 5 years, it means that the company may be getting less efficent.
During the past 12 months, Guardant Health's average Total Assets Growth Rate was 187.30% per year. During the past 3 years, the average Total Assets Growth Rate was 96.20% per year. During the past 5 years, the average Total Assets Growth Rate was 107.20% per year.
During the past 6 years, Guardant Health's highest 3-Year average Total Assets Growth Rate was 174.30%. The lowest was 57.70%. And the median was 96.20%.
Total Assets is connected with ROA %. Guardant Health's annualized ROA % for the quarter that ended in Mar. 2022 was -22.75%. Total Assets is also linked to Revenue through Asset Turnover. Guardant Health's Asset Turnover for the quarter that ended in Mar. 2022 was 0.04.
The historical data trend for Guardant Health's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Guardant Health's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as
Total Assets | = | Total Equity (A: Dec. 2021 ) | + | Total Liabilities (A: Dec. 2021 ) |
= | 645.005 | + | 1559.494 | |
= | 2,204.5 |
Guardant Health's Total Assets for the quarter that ended in Mar. 2022 is calculated as
Total Assets | = | Total Equity (Q: Mar. 2022 ) | + | Total Liabilities (Q: Mar. 2022 ) |
= | 533.04 | + | 1596.558 | |
= | 2,129.6 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Assets is connected with ROA %.
Guardant Health's annualized ROA % for the quarter that ended in Mar. 2022 is
ROA % | = | Net Income (Q: Mar. 2022 ) | / | ( (Total Assets (Q: Dec. 2021 ) | + | Total Assets (Q: Mar. 2022 )) | / count ) |
= | -492.912 | / | ( (2204.499 | + | 2129.598) | / 2 ) | |
= | -492.912 | / | 2167.0485 | ||||
= | -22.75 % |
Note: The Net Income data used here is four times the quarterly (Mar. 2022) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Guardant Health's Asset Turnover for the quarter that ended in Mar. 2022 is
Asset Turnover | ||||||
= | Revenue (Q: Mar. 2022 ) | / | ( (Total Assets (Q: Dec. 2021 ) | + | Total Assets (Q: Mar. 2022 )) | / count ) |
= | 96.099 | / | ( (2204.499 | + | 2129.598) | / 2 ) |
= | 96.099 | / | 2167.0485 | |||
= | 0.04 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Thank you for viewing the detailed overview of Guardant Health's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Talasaz Amirali | director, officer: Chairman, President and COO | 18 ISABELLA AVENUE ATHERTON CA 94027 |
Kaul Samir | director | C/O KHOSLA VENTURES 3000 SAND HILL ROAD, BLDG. 3, SUITE 170 MENLO PARK CA 94025 |
Meresman Stanley J | director | 2071 HUNTINGTON LANE LOS ALTOS CA 94024 |
Svf Bluebird (cayman) Ltd | 10 percent owner | C/O WALKERS CORPORATE LIMITED 27 HOSPITAL ROAD GEORGE TOWN E9 KY1-9008 |
Svf Enterprise (cayman) Ltd | 10 percent owner | C/O WALKERS CORPORATE LIMITED 27 HOSPITAL ROAD GEORGE TOWN E9 KY1-9008 |
Sb Investment Advisers (uk) Ltd | 10 percent owner | 69 GROSVENOR STREET LONDON X0 W1K 3JP |
Softbank Vision Fund (aiv M1) L.p. | 10 percent owner | 251 LITTLE FALLS DRIVE WILMINGTON DE 19808 |
Svf Endurance (cayman) Ltd | 10 percent owner | C/O WALKERS CORPORATE LIMITED 27 HOSPITAL ROAD GEORGE TOWN E9 KY1-9008 |
Clark Ian T | director | SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 |
Eltoukhy Helmy | director, officer: Chief Executive Officer | 2 BARRY LANE ATHERTON CA 94027 |
Bertocci Derek A | officer: Chief Financial Officer | 3070 ORCHARD DRIVE SAN JOSE CA 95134 |
Saia John G. | officer: See Remarks | C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 |
Gadde Vijaya | director | C/O TWITTER INC 1355 MARKET STREET SUITE 900 SAN FRANCISCO CA 94103 |
Jallal Bahija | director | 120 MONUMENT CIRCLE INDIANAPOLIS IN 46204 |
Nishar Dipchand | director | C/O LINKEDIN CORPORATION 2029 STIERLIN COURT MOUNTAIN VIEW CA 94043 |
From GuruFocus
Other Sources
By tipranks.com 2022-03-05
By Zacks 2022-01-26
By Zacks 2021-08-05
By tipranks.com 2022-03-10
By Zacks 2021-11-03
By tipranks.com 2022-04-05
By Fool 2022-03-18
By Zacks 2021-07-29
By tipranks.com 2022-02-16
By Zacks 2022-02-03
By Seekingalpha 2022-01-03
By Zacks 2021-11-04
By Fool 2022-04-01